Australia New Zealand Food Standards Code—Amendment No. 217
The following instruments are separate instruments in the Federal Register of Legislation and are known collectively in the Food Standards Gazette as Amendment No. 217.
The Board of Food Standards Australia New Zealand gives notice of the making of this variation under section 92 of the Food Standards Australia New Zealand Act 1991. The variation commences on the date specified in clause 3 of this variation.
Dated 17 April 2023.
Dr NICK FLETCHER, Delegate of the Board of Food Standards Australia New Zealand.
Note: This variation will be published in the Commonwealth of Australia Gazette No. FSC 157 on 21 April 2023. This means that this date is the gazettal date for the purposes of clause 3 of the variation. |
This instrument is the Food Standards (Application A1252 – Glucoamylase from GM Aspergillus niger (gene donor: Penicillium oxalicum) as a processing aid) Variation.
The Schedule varies a Standard in the Australia New Zealand Food Standards Code.
The variation commences on the date of gazettal.
[1] Subsection S18—9(3) (table)
Insert:
Glucoamylase,protein engineered variant, (EC 3.2.1.3) sourced from Aspergillus niger containing the glucoamylase gene from Penicillium oxalicum |
For use in: (a) the manufacture of bakery products; (b) brewing; and (c) starch processing for the production of starch hydrolysates, including glucose syrups. |
GMP |
The Board of Food Standards Australia New Zealand gives notice of the making of this variation under section 92 of the Food Standards Australia New Zealand Act 1991. The variation commences on the date specified in clause 3 of this variation.
Dated 17 April 2023.
Dr NICK FLETCHER, Delegate of the Board of Food Standards Australia New Zealand.
Note: This variation will be published in the Commonwealth of Australia Gazette No. FSC 157 on 21 April 2023. This means that this date is the gazettal date for the purposes of clause 3 of the variation. |
This instrument is the Food Standards (Application A1253 – Bovine Lactoferrin in Infant Formula Products) Variation.
The Schedule varies Standards in the Australia New Zealand Food Standards Code.
The variation commences on the date of gazettal.
[1] Paragraph 2.9.1—5(1)(b)
Repeal the paragraph, substitute:
(b) the amount of the substance in the product (including any naturally-occurring amount) is no more than the corresponding amount listed in Column 4 of the table; and
(c) it complies with any conditions listed in section S29—5A in relation to that substance.
[2] Subsection S3—2(2) (table)
Insert:
bovine lactoferrin |
section S3—46 |
[3] After section S3—45
Insert:
S3—46 Specification for bovine lactoferrin
(1) In this section, bovine lactoferrin is a protein derived from cow’s milk and consisting of a single polypeptide chain of 689 amino acids.
(2) For bovine lactoferrin, the specifications are the following:
(a) description—a pink to reddish brown coloured, free-flowing powder;
(b) protein (N x 6.38)—more than 93.0%;
(c) purity—more than 95.0%;
(d) moisture—less than 4.5 g/100 g;
(e) ash—not more than 1.5 g/100 g;
(f) iron—not more than 35 mg/100 g;
(g) pH (2% solution)—5.2 to 7.2;
(h) solubility transmittance (2% solution, 20°C)—transparent;
(i) lead—not more than 1 mg/kg;
(j) microbial limits:
(i)Salmonella spp.—absent in 25 g;
(ii) Listeria monocytogenes—–absent in 25 g;
(iii) Cronobacter spp.—–absent in 10 g.
[4] Section S29—5 (table)
Insert:
Lactoferrin |
Bovine lactoferrin |
40 mg |
[5] After section S29—5
Insert:
S29—5A Infant formula products—conditions on use of permitted nutritive substances
(1) A substance that is:
(a) listed in Column 1 of the table to subsection (2); and
(b) in a permitted form listed in Column 2 of that table for that substance;
must comply with any corresponding conditions specified in Column 3 of that table for that permitted form.
(2) The table for this subsection is:
Column 1 |
Column 2 |
Column 3 |
Substance |
Permitted Form |
Conditions of use |
Lactoferrin |
Bovine lactoferrin |
1. During the exclusive use period, may only be sold under the brand Synlait for *use as a nutritive substance in an infant formula product. 2. For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1253 – Bovine Lactoferrin in Infant Formula Products) Variation and ending 15 months after that date. |